Kaye Mark bought CNMD
February 24, 2025 · Form 4 insider transaction
Kaye Mark bought 152 shares of CONMED Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
152
Price
$0.00
Total value
N/A
InsiderKaye Mark
Role—
CompanyCONMED Corporation (CNMD)
SecurityRSUs (Restricted Stock Units)
Transaction codeA: Grant or award
Transaction dateFebruary 24, 2025
Filing dateFebruary 26, 2025
Shares owned after152
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.